Preliminary consolidated sales figures of JSC Olainfarm for April 2014 show that sales have reached 9.46 million euro, which represents an increase by 76% compared to the same period one year ago. The major sales increases were achieved in Ukraine, where sales grew by 13708%, sales to Georgia grew by 716%, sales to Tajikistan grew by 647%, sales to Lithuania grew by 361% and sales to Russia grew by 130%. Major sales markets of JSC Olainfarm in Aprils 2014 were Russia, Latvia, Ukraine and Belarus. Sales during this period were made to 19 countries on 2 continents.
| April 2014, consolidated results | Share in total sales | Changes to April 2013 |
| Russia | 47% | 130% |
| Latvia | 19% | 30% |
| Ukraine | 15% | 13708% |
| Belarus | 7% | 51% |
| Kazakhstan | 2% | -18% |
| Uzbekistan | 1% | -18% |
| Georgia | 1% | 716% |
| Tajikistan | 1% | 647% |
| Lithuania | 1% | 361% |
| Turkmenistan | 1% | 66% |
| Other | 3% | -70% |
| Total | 100% | 76% |
Sales of pharmacy chain Ltd. Latvijas aptieka owned by JSC Olainfarm in April of 2014 were 1.26 million euro, and 53 pharmacies were operating during this period. Sales of Ltd. Silvanols in April 2014 were 0.27 million euro.
During the first four months of 2014 according to preliminary results sales of JSC Olainfarm were 32.85 million euro, which represents an increase by 42% compared to the same period of 2013. The most rapid sales increases were achieved in Ukraine, where sales grew by 281%, sales to The Netherlands grew by 201%, while sales to Lithuania grew by 165%. Major sales markets of JSC Olainfarm during four months of 2014 were Russia, Latvia, Ukraine and Belarus. In total during four months of 2014 sales have been made to 34 countries on 5 continents.
| 4 months of 2014, consolidated results | Share in total sales | Changes to four months of 2013 |
| Russia | 38% | 26% |
| Latvia | 22% | 29% |
| Ukraine | 13% | 281% |
| Belarus | 9% | 48% |
| The Netherlands | 3% | 201% |
| UK | 3% | 2% |
| Kazakhstan | 2% | -40% |
| Uzbekistan | 1% | 31% |
| Lithuania | 1% | 165% |
| Spain | 1% | -14% |
| Other | 7% | 44% |
| Total | 100% | 42% |
Sales of pharmacy chain Latvijas aptieka Ltd., owned by JSC Olainfarm in four months were 5.1 million euro. Sales of Silvanols Ltd. during this period were 1.13 million euro.
According to preliminary unconsolidated results, the sales of JSC Olainfarm in April 2014 were 8.44 million euro, which represents an increase by 85% compared to the same period one year ago. The biggest sales increases were achieved in Ukraine, where sales grew by 13708%, sales to Georgia grew by 716%, sales to Tajikistan grew by 647%, sales to Lithuania grew by 361%, but sales to Russia grew by 130%. Major sales markets of JSC Olainfarm in April 2014 were Russia, Ukraine, Latvia and Belarus. During Aprils 2014, products of JSC Olainfarm were sold in 18 countries on two continents.
| April 2014, unconsolidated results | Share in total sales | Changes to April 2013 |
| Russia | 53% | 130% |
| Ukraine | 17% | 13708% |
| Latvia | 10% | 41% |
| Belarus | 8% | 51% |
| Kazakhstan | 3% | -18% |
| Uzbekistan | 2% | -18% |
| Georgia | 1% | 716% |
| Tajikistan | 1% | 647% |
| Lithuania | 1% | 361% |
| Turkmenistan | 1% | 66% |
| Other | 3% | -75% |
| Other | 100% | 85% |
During four months of 2014, according to preliminary results, unconsolidated sales of JSC Olainfarm were 28.41 million euro, which represents an increase by 43% compared to the same period of 2013. The most rapid sales increases were achieved in Ukraine and The Netherlands, where sales grew by 281% and 201% respectively. Sales to Tajikistan grew by 119%. According to preliminary unconsolidated results the major sales markets of JSC Olainfarm in four months of 2104 were Russia, Ukraine, Latvia and Belarus. In total during four months of 2014 products of JSC Olainfarm were sold in 32 countries on 5 continents.
| 4 months of 2014, unconsolidated results | Share in total sales | Changes to 4 months of 2013 |
| Russia | 44% | 26% |
| Ukraine | 16% | 281% |
| Latvia | 11% | 34% |
| Belarus | 11% | 48% |
| The Netherlands | 3% | 201% |
| UK | 3% | 2% |
| Kazakhstan | 2% | -40% |
| Uzbekistan | 2% | 31% |
| Spain | 1% | -14% |
| Tajikistan | 1% | 119% |
| Other | 7% | 27% |
| Total | 100% | 43% |
On April 29, 2014, on Annual General Meeting of JSC Olainfarm, operating plan of the company was approved, providing that unconsolidated sales of company in 2014 will reach 80 million euros, while consolidated sales will be as high as 93 million euro. According to these preliminary sales figures, during four months of this year 36% of annual target for unconsolidated sales and 35% of annual target for consolidated sales have been achieved.
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information prepared by:
Salvis Lapins
Member of the Board
JSC Olainfarm
Tel: +371 6 7013 717
Cell: +371 2 6448 873
E-mail: slapinsh@olainfarm.lv
